AVGR - Avinger, Inc.
NASDAQ
->
Healthcare
->
Medical Devices
Redwood City,
United States
Type: Equity
AVGR price evolution
AVGR
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $8.81 | $7.17 | $5.28 | |
| Short term investments | ||||
| Net receivables | $0.88 | $0.93 | $1.38 | $1.01 |
| Inventory | $3.76 | $4.12 | $4.56 | $5.3 |
| Total current assets | $11.48 | $14.9 | $14.12 | $12.16 |
| Long term investments | ||||
| Property, plant & equipment | $1.89 | $2.17 | $2.51 | $1.59 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.4 | $2.74 | $1.61 | |
| Total investments | ||||
| Total assets | $13.6 | $17.3 | $16.86 | $13.77 |
| Current liabilities | ||||
| Accounts payable | $0.92 | $0.72 | $0.75 | $0.78 |
| Deferred revenue | ||||
| Short long term debt | $4.04 | $14.75 | $14.29 | |
| Total current liabilities | $9.5 | $9 | $20.06 | $19.3 |
| Long term debt | ||||
| Total noncurrent liabilities | $0.54 | $0.85 | $0.67 | |
| Total debt | $4.04 | $14.75 | $14.29 | |
| Total liabilities | $9.73 | $9.54 | $20.91 | $19.97 |
| Shareholders' equity | ||||
| Retained earnings | -$434.28 | -$430.57 | -$426.21 | -$420.7 |
| Other shareholder equity | ||||
| Total shareholder equity | $7.75 | -$4.05 | -$6.2 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $5.28 | $14.6 | $19.5 | $22.18 |
| Short term investments | ||||
| Net receivables | $1.01 | $1.06 | $1.39 | $1.48 |
| Inventory | $5.3 | $4.96 | $4.6 | $3.88 |
| Total current assets | $12.16 | $20.99 | $25.79 | $27.89 |
| Long term investments | ||||
| Property, plant & equipment | $1.59 | $2.9 | $3.27 | $4.79 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.61 | $3.21 | $3.69 | $5.3 |
| Total investments | ||||
| Total assets | $13.77 | $24.2 | $29.48 | $33.2 |
| Current liabilities | ||||
| Accounts payable | $0.78 | $0.63 | $1.39 | $0.69 |
| Deferred revenue | ||||
| Short long term debt | $14.29 | $14.16 | $3.59 | |
| Total current liabilities | $19.3 | $17.95 | $4.71 | $7.46 |
| Long term debt | $12.29 | $9.4 | ||
| Total noncurrent liabilities | $0.67 | $2.1 | $15.06 | $12.66 |
| Total debt | $14.29 | $14.16 | $12.29 | $12.99 |
| Total liabilities | $19.97 | $20.05 | $19.76 | $20.12 |
| Shareholders' equity | ||||
| Retained earnings | -$420.7 | -$402.38 | -$384.75 | -$367.34 |
| Other shareholder equity | ||||
| Total shareholder equity | -$6.2 | $4.15 | $9.72 | $13.08 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.85 | $1.86 | $1.91 | |
| Cost of revenue | $1.47 | $1.52 | $1.53 | |
| Gross Profit | $0.38 | $0.34 | $0.37 | |
| Operating activities | ||||
| Research & development | $0.9 | $1.06 | $1.15 | |
| Selling, general & administrative | $3.6 | $4.37 | $3.84 | |
| Total operating expenses | $4.5 | $5.43 | $4.99 | |
| Operating income | -$4.13 | -$5.09 | -$4.62 | |
| Income from continuing operations | ||||
| EBIT | -$4.13 | -$5.1 | -$4.6 | |
| Income tax expense | ||||
| Interest expense | $0.23 | $0.42 | $0.43 | |
| Net income | ||||
| Net income | -$4.36 | -$5.52 | -$5.02 | |
| Income (for common shares) | -$4.6 | -$3.67 | -$5.02 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $7.65 | $8.27 | $10.13 | $8.76 |
| Cost of revenue | $5.65 | $5.62 | $6.71 | $6.14 |
| Gross Profit | $2 | $2.65 | $3.42 | $2.62 |
| Operating activities | ||||
| Research & development | $4.54 | $4.39 | $5.9 | $5.7 |
| Selling, general & administrative | $14.1 | $14.22 | $15.63 | $14.33 |
| Total operating expenses | $18.64 | $18.61 | $21.52 | $20.02 |
| Operating income | -$16.64 | -$15.96 | -$18.1 | -$17.4 |
| Income from continuing operations | ||||
| EBIT | -$16.6 | -$15.96 | -$15.76 | -$17.31 |
| Income tax expense | ||||
| Interest expense | $1.72 | $1.67 | $1.65 | $1.69 |
| Net income | ||||
| Net income | -$18.32 | -$17.62 | -$17.41 | -$19.01 |
| Income (for common shares) | -$18.32 | -$27.24 | -$21.59 | -$22.87 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$4.36 | -$5.52 | -$5.02 | |
| Operating activities | ||||
| Depreciation | $0.09 | $0.08 | $0.07 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.21 | $1.1 | $0.24 | |
| Total cash flows from operations | -$3.57 | -$4.73 | -$3.39 | |
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.2 | $6.63 | -$0.06 | |
| Net borrowings | ||||
| Total cash flows from financing | $11.79 | $5.2 | $6.63 | -$0.06 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.63 | $1.63 | $1.9 | -$3.45 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$18.32 | -$17.62 | -$17.41 | -$19.01 |
| Operating activities | ||||
| Depreciation | $0.29 | $0.2 | $0.69 | $0.9 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.94 | $0.13 | $1.01 | $1.51 |
| Total cash flows from operations | -$14.43 | -$16.76 | -$15.7 | -$14.84 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.05 | -$0.03 | $0.07 |
| Investments | ||||
| Total cash flows from investing | -$0.01 | -$0.05 | -$0.03 | $0.07 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $5.11 | $5.2 | $13.04 | $23.68 |
| Net borrowings | $2.33 | |||
| Total cash flows from financing | $5.11 | $11.92 | $13.04 | $26.01 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$9.33 | -$4.89 | -$2.69 | $11.24 |
News
Fundamentals
| Market cap | $1.32M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 2.78M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | -3.22 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.21 |
| Quick ratio | 0.81 |